Medical News

RSS

Study: Sleep disturbances can hamper memory processes in children

Sleep disordered breathing can hamper memory processes in children, according to a new study. The research, which will be presented today at the Sleep and Breathing Conference (16 April 2015), found that disrupted sleep had an impact on different memory processes and how children learn.

15 Apr 2015

New UV light method could help stop spread of hospital superbugs

Can a robot clean a hospital room just as well as a person? According to new research out of the Texas A&M Health Science Center College of Medicine, that is indeed the case. Chetan Jinadatha, M.D., M.P.H., assistant professor at the Texas A&M College of Medicine and chief of infectious diseases at the Central Texas Veterans Health Care System in Temple, is studying the effectiveness of a germ-zapping robot to clean hospital rooms, which could hold the key to preventing the spread of "superbugs" - in turn, saving countless dollars and, most importantly, lives.

15 Apr 2015

New herbal tea to treat malaria in Africa

Malaria is a critical health problem in West Africa, where traditional medicine is commonly used alongside modern healthcare practices. An herbal remedy derived from the roots of a weed, which was traditionally used to alleviate malarial symptoms, was combined with leaves and aerial portions from two other plants with antimalarial activity, formulated as a tea, and eventually licensed and sold as an antimalarial phytomedicine.

15 Apr 2015

New Forsyth Institute study sheds light on connection between the mouth and heart

A new study from the Forsyth Institute is helping to shed more light on the important connection between the mouth and heart. According to research recently published online by the American Heart Association, scientists at Forsyth and Boston University have demonstrated that using an oral topical remedy to reduce inflammation associated with periodontitis, more commonly known as gum disease, also results in the prevention of vascular inflammation and can lower the risk of heart attack.

15 Apr 2015

Johns Hopkins researchers link sperm with specific 'epigenetic tags' to autism

In a small study, Johns Hopkins researchers found that DNA from the sperm of men whose children had early signs of autism shows distinct patterns of regulatory tags that could contribute to the condition. A detailed report of their findings will be published online in the International Journal of Epidemiology on April 15.

15 Apr 2015

Changes in JAK/STAT3 cell signaling pathway drive ALK-negative ALCL

The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a particularly aggressive form of non-Hodgkin's lymphoma, shows that many cases of the disease are driven by alterations in the JAK/STAT3 cell signaling pathway.

15 Apr 2015

Ancient natural compound can protect the heart from hypertrophy

A natural compound derived from the bark of the magnolia tree, can protect the heart from hypertrophy, a thickening of cardiac muscle often caused by chronic high blood pressure that can lead to heart failure, researchers report in the April 14 issue of the online journal Nature Communications.

15 Apr 2015

Scientists find link between higher muscle mass and healthier bone development in children

Scientists at the University of Southampton have shown that higher muscle mass is strongly linked with healthier bone development in children.

15 Apr 2015

Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Focus Diagnostics, the clinical-laboratory products business of Quest Diagnostics, today announced the FDA 510(k) clearance and CLIA moderate-complexity categorization for its Simplexa Group A Strep Direct Kit. Simplexa Group A Strep Direct is a real-time polymerase chain reaction assay for the detection of Group A Streptococcus bacteria directly from throat swabs.

From Quest Diagnostics 15 Apr 2015

Pivotal enters into sales, distribution agreement for BeneFishial family of products

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that it has entered into a Memorandum of Understanding with Korea Animal Medical Science Institute and its newly created affiliate for the exclusive sales and distribution of the BeneFishial family of products.

15 Apr 2015

SELLAS inks exclusive global collaboration, license agreement with TrojanTec

SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.

15 Apr 2015

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

15 Apr 2015

Optibrium to integrate ChemAxon's Plexus with StarDrop software platform

Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon's Plexus with Optibrium's StarDrop software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.

15 Apr 2015

WHO issues public statement calling for transparency in medical research

WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.

15 Apr 2015

New Clinical Conductor CTMS functionality helps healthcare organizations better manage clinical research

The team behind Clinical Conductor CTMS recently debuted new functionality that allows healthcare organizations to better manage adaptive and dynamic clinical research that is becoming more relevant in the industry every year. Included in this quarter’s release is functionality that lets users create snapshots of past budgets to be used for better negotiations and invoicing, the ability for organizations to create multiple charge masters, and functionality that provides better handling of protocol amendments.

15 Apr 2015

Study: Children with type 1 diabetes five times more likely to be admitted to hospital

Children living with type 1 diabetes are nearly five times more likely to be admitted to hospital than non-diabetic children, a new study (attached) has found.

15 Apr 2015

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

There are roughly 10 million people worldwide taking Warfarin, accounting for more than 200 million point of care (POC) PT-INR tests performed globally each year...

15 Apr 2015

Clyde Biosciences announces £2 million ‘Series A’ investment

Clyde Biosciences Ltd. has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund.

15 Apr 2015

Sterillo: The world's most hygienic hand dryer destroys bacteria and viruses

Research by Sterillo, the world's most hygienic hand dryer, has revealed a nation attempting to dodge germs and smelly washrooms. Whilst they are in fact, ignorantly smothering themselves in germs and bacteria every time they visit a public or restaurant toilet.

15 Apr 2015

Innovative liver cancer treatment gets EU approval

A new treatment for liver cancer developed by the University Medical Center (UMC) Utrecht has received the European CE mark for quality and safety.

15 Apr 2015

Medical News

Study: Sleep disturbances can hamper memory processes in children

New UV light method could help stop spread of hospital superbugs

New herbal tea to treat malaria in Africa

New Forsyth Institute study sheds light on connection between the mouth and heart

Johns Hopkins researchers link sperm with specific 'epigenetic tags' to autism

Changes in JAK/STAT3 cell signaling pathway drive ALK-negative ALCL

Ancient natural compound can protect the heart from hypertrophy

Scientists find link between higher muscle mass and healthier bone development in children

Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Pivotal enters into sales, distribution agreement for BeneFishial family of products

SELLAS inks exclusive global collaboration, license agreement with TrojanTec

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

Optibrium to integrate ChemAxon's Plexus with StarDrop software platform

WHO issues public statement calling for transparency in medical research

New Clinical Conductor CTMS functionality helps healthcare organizations better manage clinical research

Study: Children with type 1 diabetes five times more likely to be admitted to hospital

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

Clyde Biosciences announces £2 million ‘Series A’ investment

Sterillo: The world's most hygienic hand dryer destroys bacteria and viruses

Innovative liver cancer treatment gets EU approval

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News